Abstract
The factors that have been implicated in renin release are shown in Table 1; they may be divided into acute and chronic factors as illustrated by the difference between the rise of plasma renin activity on standing compared with the slower increase under the influence of sodium deprivation. In examining the situation in normal man, it is important to try to incorporate the findings from various other types of experimental studies, ranging from the isolated perfused kidney to the kidney perfused in situ with and without an intact tubular system. Much more is known about the acute situation in man and animals and, while this is sometimes difficult to interpret, the chronic situation with some exceptions is not very well understood. Again, in trying to understand the normal situation in man, it is necessary to draw on pathological changes and to see how they may reveal some of the important mechanisms in the normal physiological state.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Tobian L: Interrelationship of electrolytes, juxtaglomerular cells and hypertension. Physiol Rev 40:280–312, 1960.
Thurau K, Schnermann J: Die Natriumkonzentration an den Macula densa-Zellen als regulierender Faktor för das Glomerulumfiltrat. Klin Wochenschr 43:410–413, 1965.
Thurau K, Dahlheim H, Gröner A, Mason J, Granger P: Activation of renin in the single juxtaglomerular apparatus by sodium chloride in the tubular fluid at the macula densa. Circ Res 30–31 (Suppl.II): 182–186, 1972.
Schnermann J: Regulation of filtrate formation by feedback, in Giovanetti S, Bonomini V, D’Amico G (eds): Proceedings of the Sixth International Congress on Nephrology. Basel, Karger, 1976, pp 230–234.
Davis JO: The regulation of renin release, in Onesti G, Kim KE, Moyer JH (eds): Hypertension: Mechanisms and Management. New York, Grune & Stratton, 1973, pp 617–629.
Davis JO: The control of renin release. Am J Med 55:333–350, 1973.
Horton R: Stimulation and suppression of aldosterone in plasma of normal man and in primary aldosteronism. J Clin Invest 48:1230–1236, 1969.
Katz FH, Romfh P, Smith JA: Episodic secretion of aldosterone in supine man: Relationship to Cortisol. J Clin Endocrinol Metab 35:178–181, 1972.
Vetter H, Berger M, Armbruster H, Siegenthaler W, Werning C, Vetter W: Episodic secretion of aldosterone in primary aldosteronism: Relationship to Cortisol. Clin Endocrinol 3:41–48, 1974.
Katz FH, Romfh P, Smith JA: Diurnal variation of plasma aldosterone, Cortisol and renin activity in supine man. J Clin Endocrinol Metab 40:125–134, 1975.
Weinberger MH, Kem DC, Gomez-Sanchez C, Kramer NJ, Martin BT, Nugent CA: The effect of dexamethasone on the control of plasma aldosterone concentration in normal recumbent man. J Lab Clin Med 85:957–967, 1975.
Armbruster H, Vetter W, Beckerhoff R, Nussberger J, Vetter H, Siegenthaler W: Dirunal variations of plasma aldosterone in supine man: Relationship to plasma renin activity and plasma Cortisol. Acta Endocrinol (Kbh) 80:95–103, 1975.
James VHT, Tunbridge RDG, Wilson GA: Studies on the control of aldosterone secretion in man. J Steroid Biochem 7:941–948, 1976.
Gordon RD, Köchel O, Liddle GW, Island DP: Role of the sympathetic nervous system in regulating renin and aldosterone production in man. J Clin Invest 46:599–605, 1967.
Michelakis AM, McAllister RG: The effect of chronic adrenergic receptor blockage on plasma renin activity in man. J Clin Endocrinol Metab 34:386–394, 1972.
Vander AJ: Effect of catecholamines and the renal nerves on renin secretion in anesthetized dogs. Am J Physiol 209:659–661, 1965.
Ganong WF: Sympathetic effects on renin secretion. Mechanism and physiological role, in Assaykeen TA (ed): Control of Renin Secretion. New York, Plenum Press, 1972, pp 17–32.
Johns EJ, Singer B: Specificity of blockage of renal renin release by propranolol in the cat. Clin Sci Mol Med 47:331–343, 1974.
Taher MS, McLain LG, McDonald KM, Schrier RW: Effect of beta adrenergic blockage on renin response to renal nerve stimulation. J Clin Invest 57:459–465, 1976.
Guttmann L, Munro AF, Robinson R, Walsh JJ: Effect of tilting on the cardiovascular responses and plasma catecholamine levels in spinal man. Paraplegia 1:4–18, 1963.
Corbett JL, Frankel HL, Harris PJ: Cardiovascular responses to tilting in tetraplegic man. J Physiol (Lond) 215:411–431, 1971.
Debarge O, Christensen NJ, Corbett JL, Eidelman BH, Frankel HL, Mathias CJ: Plasma catecholamines in tetraplegics. Paraplegia 12:44–49, 1974.
Corbett, JL, Frankel HL, Harris PJ: Cardiovascular changes associated with skeletal muscle spasm in tetraplegic man. J Physiol (Lond) 215:381–393, 1971.
Corbett JL, Frankel HL, Harris PJ: Cardiovascular reflex responses to cutaneous and visceral stimuli in spinal man. J Physiol (Lond) 215:395–409, 1971.
Corbett JL, Debarge O, Frankel HL, Mathias CJ: Cardiovascular responses in tetraplegic man to muscle spasm, bladder percussion and head-up tilt. Clin Exp Pharmacol Physiol suppl 2:189–193, 1975.
Guttmann, L Whitteridge D: Effects of bladder distension on autonomic mechanism after spinal cord injuries. Brain 70:361–404, 1947.
Mathias CJ, Christensen NJ, Corbett JL, Frankel HL, Spalding JMK: Plasma catecholamines during aproxysmal neurogenic hypertension in quadriplegic man. Circ Res 39:204–208, 1976.
Mathias CJ, Christensen NJ, Corbett JL, Frankel HL, Goodwin TJ, Peart WS: Plasma catecholamines, plasma renin activity and plasma aldosterone in tetraplegic man, horizontal and tilted. Clin Sci Mol Med 49:291–299, 1975.
Johnson RH, Park D, Frankel HL: Orthostatic hypotension and the renin-angiotensin system in paraplegia. Paraplegia 9:146–152, 1971.
Mendelsohn FA, Johnston CI: Renin release in chronic paraplegia. Aust NZ J Med 4:393–397, 1971.
Balikian HM, Brodie AH, Dale SL, Melby JC, Tait JF: Effect of posture on the metabolic clearance rate, plasma concentration and blood production rate of aldosterone in man. J Clin Endocrinol Metab 28:1630–1640, 1968.
Shy GM, Drager GA: A neurological syndrome associated with orthostatic hypotension. Arch Neurol 2:511–527, 1960.
Johnson RH, Lee G de J, Oppenheimer DR, Spalding JMK: Autonomic failure with orthostatic hypotension due to intermediolateral column degeneration. Q J Med 35:276–292, 1966.
Bannister R, Oppenheimer DR: Degenerative diseases of the nervous system associated with autonomic failure. Brain 95:457–474, 1972.
Bannister R, Ardill L, Fentem P: Defective autonomic control of blood vessels in idiopathic orthostatic hypotension. Brain 90:725–746, 1967
Bannister R: Degeneration of the autonomic nervous system. Lancet 2:175–179, 1971.
Bannister R, Sever PS, Gross M: Cardiovascular reflexes and biochemical responses in progressive autonomic failure. Brain 100:327–344, 1977.
Assaykeen TA, Clayton PL, Goldfien A, Ganong WF: Effect of alpha- and beta-adrenergic blocking agents on the renin response to hypoglycaemia and epinephrine in dogs. Endocrinology 87:1318–1322, 1970.
Ueda H, Yasuda H, Takabatake Y, Iizuka M, Iizuka T, Ihori M, Sakamoto Y: Observations on the mechanism of renin release by catecholamines. Circ Res 26 & 27(suppl II): 195–200, 1970.
Vandongen R, Peart WS, Boyd GW: Adrenergic stimulation of renin secretion in the isolated perfused rat kidney. Circ Res 32:290–296, 1973.
Vandongen R, Peart WS: The inhibition of renin secretion by alpha-adrenergic stimulation of the isolated rat kidney. Clni Sci Mol Med 47:471–479, 1974.
Eide I, L∅yning E, Kiil F: Evidence for hemodynamic autoregulation of renin release. Circ Res 32:237–245, 1973.
Brown JJ, Davies DL, Lever AF, Robertson JIS: Influence of sodium loading and sodium depletion on plasma-renin in man. Lancet 2:278–279, 1963.
Boyd GW, Adamson AR, Arnold M, James VHT, Peart WS: The role of angiotensin II in the control of aldosterone in man. Clin Sci 42:91–104, 1972.
Ledingham JM, Cohen RD: Changes in extracellular fluid volumes and cardiac output during the development of experimental renal hypertension. Can Med Assoc J 90:292–294, 1964.
Bianchi G, Tilde-Tenconi L, Lucca R: Effect in the conscious dog of constriction of the renal artery to a sole remaining kidney on haemodynamics, sodium balance, body fluid volumes, plasma renin concentration and pressor response to angiotensin. Clin Sci 38:741–766, 1970.
Liard J-F, Peters G: Role of the retention of water and sodium in two types of experimental renovascular hypertension in the rat. Pflügers Arch 344:93–108, 1973.
Liard J-F, Cowley AW Jr, McCaa RE, McCaa CS, Guyton AC: Renin, aldosterone, body fluid volumes, and the baroreceptor reflex in the development and reversal of Gold-blatt hypertention in conscious dogs. Circ Res 34:549–560, 1974.
Vaughan ED Jr, Laragh JH, Gavras I, Bühler FR, Gavras H, Brunner HR, Baer, L: Volume factor in low and normal renin essential hypertension. Treatment with either spironolactone or chlorthalidone. Am J Cardiol 32:523–532, 1973.
Tarazi RC: Diuretic drugs: Mechanisms of antihypertensive action, in Onesti G, Kim KE, Moyer JH (eds): Hypertension: Mechanisms and Management. New York, Grune & Stratton, 1973, pp 251–260.
Bravo EL, Tarazi RC, Duston HP: β-adrenergic blockade in diuretic-treated patients with essential hypertension. N EnglJ Med 292:66–70, 1975.
Lancaster R, Goodwin TJ, Peart WS: The effect of pindolol on plasma renin activity and blood pressure in hypertensive patients. Br J Clin Pharmacol 3:453–460, 1976.
Conn JW: An overall view of primary aldosteronism, Onesti G, Kim KE, Moyer JH (eds): Hypertension: Mechanisms and Management. New York, Grune & Stratton, 1973, pp 471–480.
Brown JJ, Davies DL, Lever AF, Peart WS, Robertson JIS: Plasma concentration of renin in a patient with Conn’s syndrome with fibrinoid lesions of the renal arterioles: The effect of treatment with Spironolactone. J Endocrinol 33:279–293, 1965.
Brown JJ, Davies DL, Lever AF, Robertson JIS, Verniory A: The effect of acute haemorrhage in the dog and man on plasma-renin concentration. J Physiol (Lond) 182:649–663, 1966.
Vander AJ, Geelhoed GW: Inhibition of renin secretion by angiotensin II. Proc Soc Exp Biol Med 120:399–403, 1965.
Bunag RD, Page IH, McCubbin JW: Inhibition of renin release by vasopressin and angiotensin. Cardiovasc Res 1:67–73, 1967.
Vandongen R, Peart WS, Boyd GW: Effect of angiotensin II and its nonpressor derivatives on renin secretion. Am J Physiol 226:277–282, 1974.
Freeman RH, Davis JO, Vitale SJ, Johnson JA: Intrarenal role of angiotensin II. Homeostatic regulation of renal blood flow in the dog. Circ Res 32:692–698, 1973.
Vandongen R, Peart WS: Calcium dependence of the inhibitory effect of angiotensin on renin secretion in the isolated perfused kidney of the rat. Br J Pharmacol 50:125–129, 1974.
Peart WS, Quesada T, Tenyi I: The effects of EDTA and EGTA on renin secretion. Br J Pharmacol 59:247–252, 1977.
Fynn M, Onomakpome N, Peart WS: The effects of ionophores (A23187 and R02–2985) on renin secretion and renal vasoconstriction. Proc R Soc Lond B 199:199–212 (1977).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1980 Plenum Publishing Corporation
About this chapter
Cite this chapter
Peart, W.S. (1980). The Influence of Various Neurological Defects on the Release of Renin in Normal Man. In: Case, D.B., Sonnenblick, E.H., Laragh, J.H. (eds) Captopril and Hypertension. Topics in Cardiovascular Disease. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-9179-5_4
Download citation
DOI: https://doi.org/10.1007/978-1-4615-9179-5_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4615-9181-8
Online ISBN: 978-1-4615-9179-5
eBook Packages: Springer Book Archive